Business · 26/02/2016
FDA Renews Gastrointestinal Drugs Advisory Committee for 2 Years
The FDA is renewing the Gastrointestinal Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on March 3, 2018.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →